Created Gli-1 duplex short-RNA (i-Gli-RNA) eliminates CD44 Hi progenitors of taxol-resistant ovarian cancer cells.
Created Gli-1 duplex short-RNA (i-Gli-RNA) eliminates CD44 Hi progenitors of taxol-resistant ovarian cancer cells.
复制标题
DOI:
10.3892/or_00000793
复制
发表时间:
2010-06
期刊:
影响因子:
4.2
通讯作者:
Ioannides CG
中科院分区:
文献类型:
--
作者:
Mine T;Matsueda S;Gao H;Li Y;Wong KK;Peoples GE;Ferrone S;Ioannides CG
Notch and Hedgehog activate cell-cycle progression of adult and cancer stem cells. Notch is activated by DLL and Jag presents on neighboring cells. We investigated the effects of density of the Notch-activating ligand, Jag-1, and targeting Gli-1, in activation of division of paclitaxel/taxol-resistant, (PTXRes) ovarian cancer cells SKOV3 (SKOV3). We used the specific γ-presenilin inhibitor, DAPT, to identify the specificity of activating signals for Notch-1 and created ‘butterfly-duplex-3548-Gli-1-inhibitory RNA’ (i-Gli-1.RNA) to inhibit cell division. To accurately quantify kinetics of division, the expression of CD44 and CD24 was determined in each gated population of divided cells. CD44High proliferated when activated by Jag-1Low and poorly when activated by Jag-1High. DAPT inhibited proliferation of cells activated by Jag-1Low, and increased proliferation of cells activated by Jag-1High. Only 5–10% of cells activated by Jag-1High and Jag-1Low divided fast, polynomial, and symmetric. i-Gli-1.RNA eliminated more than 50% of the small CD44High/CD24Neg cells in divisions 3 and 4. This effect appeared specific compared with cells transfected with negative control siRNA. i-Gli-1.RNA had no effect on large CD44High/CD24Neg cells, but inhibited the population of CD44High/CD24Low cells. Expansion of CD44High inversely correlated with Jag-1 density on activating autologous tumor and fibrosarcoma cells. Created i-RNAs may decrease the resting CSC pool. Notch and Gli-1 signals play an important role in proliferation/division and survival of cancer stem cells. Targeting Notch-1 through its enhancer Gl-1, should be significant for novel treatments to eliminate taxol-resistant cancer stem cells (CSC). i.Gli-1 RNA should be more effective if used together with Taxol.
登录
查看更多内容
影响因子:
11.2
作者:
Zhang, Shu;Balch, Curt;Nephew, Kenneth P.
通讯作者:
Nephew, Kenneth P.
DOI:
10.1073/pnas.0603371103
发表时间:
2006-06-13
影响因子:
11.1
作者:
Klinakis, Apostolos;Szaboics, Matthias;Efstratiadis, Argiris
通讯作者:
Efstratiadis, Argiris
影响因子:
11.2
作者:
Liu, ZJ;Xiao, M;Herlyn, M
通讯作者:
Herlyn, M
DOI:
10.1083/jcb.200712159
发表时间:
2008-01-28
期刊:
The Journal of cell biology
影响因子:
--
作者:
Lin H
通讯作者:
Lin H
DOI:
10.1073/pnas.0711613105
发表时间:
2008-02-05
影响因子:
11.1
作者:
Liu, Suling;Ginestier, Christophe;Wicha, Max S.
通讯作者:
Wicha, Max S.